- Home
- Publications
- Publication Search
- Publication Details
Title
CD73 as a potential opportunity for cancer immunotherapy
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 23, Issue 2, Pages 127-142
Publisher
Informa UK Limited
Online
2018-12-18
DOI
10.1080/14728222.2019.1559829
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice
- (2018) Ghasem Ghalamfarsa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
- (2018) Limo Chen et al. Cancer Discovery
- A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
- (2018) Stephen B. Willingham et al. Cancer Immunology Research
- Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
- (2017) Mohammad H. Kazemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
- (2017) Farhad Jadidi-Niaragh et al. JOURNAL OF CONTROLLED RELEASE
- Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
- (2017) Silvana Morello et al. Journal of Translational Medicine
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action
- (2016) James C. Geoghegan et al. mAbs
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles
- (2016) Farhad Jadidi-Niaragh et al. TUMOR BIOLOGY
- Targeting CD73 in the tumor microenvironment with MEDI9447
- (2016) Carl M. Hay et al. OncoImmunology
- CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
- (2015) Martin Turcotte et al. CANCER RESEARCH
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
- (2015) Paul A. Beavis et al. Cancer Immunology Research
- CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis
- (2014) A. Mikhailov et al. JOURNAL OF IMMUNOLOGY
- CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
- (2014) Masahide Takedachi et al. JOURNAL OF IMMUNOLOGY
- The Roles of CD73 in Cancer
- (2014) Zhao-wei Gao et al. Biomed Research International
- Increased Frequency of CD8+and CD4+Regulatory T Cells in Chronic Lymphocytic Leukemia: Association with Disease Progression
- (2013) Farhad Jadidi-Niaragh et al. CANCER INVESTIGATION
- NT5E and FcGBP as key regulators of TGF-1-induced epithelial–mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer
- (2013) Li Xiong et al. CELL AND TISSUE RESEARCH
- Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
- (2013) B. Allard et al. CLINICAL CANCER RESEARCH
- Anti-CD73 therapy impairs tumor angiogenesis
- (2013) Bertrand Allard et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of CD73 in Prostate Cancer is Associated with Lymph Node Metastasis
- (2013) Qing Yang et al. PATHOLOGY & ONCOLOGY RESEARCH
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions
- (2013) Farhad Jadidi-Niaragh et al. TUMOR BIOLOGY
- Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma
- (2013) Xiao-Xia Lu WORLD JOURNAL OF GASTROENTEROLOGY
- NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
- (2012) H Wang et al. BRITISH JOURNAL OF CANCER
- CD73-Deficient Mice Are Resistant to Carcinogenesis
- (2012) J. Stagg et al. CANCER RESEARCH
- Crystal Structure of a Soluble Form of Human CD73 with Ecto-5′-Nucleotidase Activity
- (2012) Dominic P. H. M. Heuts et al. CHEMBIOCHEM
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- (2012) Fanny Chalmin et al. IMMUNITY
- Opportunities and challenges for anti-CD73 cancer therapy
- (2012) Bin Zhang Immunotherapy
- Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration
- (2012) Hoon Kyu Oh et al. Journal of Gynecologic Oncology
- Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma
- (2012) G. Forte et al. JOURNAL OF IMMUNOLOGY
- CD73 as a novel prognostic biomarker for human colorectal cancer
- (2012) Nan Liu et al. JOURNAL OF SURGICAL ONCOLOGY
- High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
- (2012) Xian-Rui Wu et al. JOURNAL OF SURGICAL ONCOLOGY
- ENTPD1/CD39 is a promising therapeutic target in oncology
- (2012) J Bastid et al. ONCOGENE
- Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
- (2012) Karen Knapp et al. STRUCTURE
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia
- (2012) Farhad Jadidi-Niaragh et al. TUMOR BIOLOGY
- CD73 promotes tumor growth and metastasis
- (2012) Bin Zhang OncoImmunology
- Different role of CD73 in leukocyte trafficking via blood and lymph vessels
- (2011) A. Algars et al. BLOOD
- New markers for minimal residual disease detection in acute lymphoblastic leukemia
- (2011) E. Coustan-Smith et al. BLOOD
- CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
- (2011) S. Serra et al. BLOOD
- Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
- (2011) Sebastian F. M. Häusler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
- (2011) J. Stagg et al. CANCER RESEARCH
- Generation of anti-inflammatory adenosine byleukocytes is regulated by TGF-β
- (2011) Frederico S. Regateiro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
- (2011) Gennady G. Yegutkin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- CD73 (5′-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia
- (2011) E Wieten et al. LEUKEMIA
- NT5EMutations and Arterial Calcifications
- (2011) Cynthia St. Hilaire et al. NEW ENGLAND JOURNAL OF MEDICINE
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells
- (2011) Liliana Rockenbach et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
- (2011) Anna Supernat et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells
- (2010) Xiuling Zhi et al. CANCER SCIENCE
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deficiency or Inhibition of CD73 Protects in Mild Kidney Ischemia-Reperfusion Injury
- (2010) Siddharth V. Rajakumar et al. TRANSPLANTATION
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
- (2009) M. Mandapathil et al. CLINICAL CANCER RESEARCH
- A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments
- (2009) A. Ohta et al. JOURNAL OF IMMUNOLOGY
- Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry
- (2009) Rikke Leth-Larsen et al. MOLECULAR & CELLULAR PROTEOMICS
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Ectonucleotidases in the kidney
- (2009) David G. Shirley et al. Purinergic Signalling
- Differential ectonucleotidase expression in human bladder cancer cell lines
- (2009) Joséli Stella et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
- (2008) Gennady G. Yegutkin BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
- (2008) H. K. Eltzschig et al. BLOOD
- The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
- (2008) Luci Bavaresco et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
- (2008) Patrizia Pellegatti et al. PLoS One
- CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
- (2008) J. H. Mills et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started